» Articles » PMID: 35698002

Recent Developments and Advances in Atopic Dermatitis: A Focus on Epidemiology, Pathophysiology, and Treatment in the Pediatric Setting

Overview
Journal Paediatr Drugs
Specialties Pediatrics
Pharmacology
Date 2022 Jun 13
PMID 35698002
Authors
Affiliations
Soon will be listed here.
Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disorder that affects a substantial number of children and has a significant negative impact on affected patients and their caregivers/families. Recent studies have led to significant evolutions in the understanding of AD pathogenesis, epidemiology, and treatment. The first point of contact for many patients with new-onset AD is usually with their primary care provider or pediatrician. This underscores the importance for pediatricians to understand the basic pathophysiology and current standards of care for AD. This article provides up-to-date information and reviews the basic principles of AD pathophysiology, diagnosis, and management. In addition, the article highlights recent advances in scientific research regarding the mechanisms involved in the pathogenesis of atopic dermatitis that have resulted in the discovery of novel therapeutic targets and the development of targeted biologic therapies with the potential to revolutionize AD therapy.

Citing Articles

Managing Childhood and Adolescent Atopic Dermatitis in Primary Care: A US Expert Group Consensus.

Boguniewicz M, Levy M, Eichenfield L, Lauren C, Leung D, Schneider L J Pediatr Clin Pract. 2025; 14:200121.

PMID: 39950052 PMC: 11824657. DOI: 10.1016/j.jpedcp.2024.200121.


Changes and clinical significance of serum vitamin A, 25-(OH)D3, TG2, IL-4 and IL-13 levels in children with eczema.

Li Y, Wang Z, Li X, Ma K, Shi Z Arch Dermatol Res. 2025; 317(1):375.

PMID: 39921740 DOI: 10.1007/s00403-025-03887-8.


The primary mechanisms underlying atopic dermatitis.

Missaoui S, Gaadi A, Oussama K, Adam Z, Bousfiha A, Hali F Tunis Med. 2025; 103(1):65-72.

PMID: 39812196 PMC: 11906244. DOI: 10.62438/tunismed.v103i1.5220.


Differential Expression of Proteins Involved in Skin Barrier Maintenance and Vitamin D Metabolism in Atopic Dermatitis: A Cross-Sectional, Exploratory Study.

Grieco T, Paolino G, Moliterni E, Chello C, Sernicola A, Egan C Int J Mol Sci. 2025; 26(1.

PMID: 39796069 PMC: 11719518. DOI: 10.3390/ijms26010211.


The Impact of Immune Cells, Metabolites, Inflammatory Factors, and Circulating Proteins on Atopic Dermatitis: Insights from a Mendelian Randomization Study.

Zhou D, Gan G, Song S, Zi C, Bao Y, Hao W Clin Cosmet Investig Dermatol. 2024; 17:2999-3011.

PMID: 39723341 PMC: 11669345. DOI: 10.2147/CCID.S495217.


References
1.
Silverberg J, Simpson E . Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization. Pediatr Allergy Immunol. 2013; 24(5):476-86. PMC: 4397968. DOI: 10.1111/pai.12095. View

2.
Nutten S . Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015; 66 Suppl 1:8-16. DOI: 10.1159/000370220. View

3.
Eichenfield L, Tom W, Chamlin S, Feldman S, Hanifin J, Simpson E . Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2013; 70(2):338-51. PMC: 4410183. DOI: 10.1016/j.jaad.2013.10.010. View

4.
Wang J, Ramette A, Jurca M, Goutaki M, Beardsmore C, Kuehni C . Association between breastfeeding and eczema during childhood and adolescence: A cohort study. PLoS One. 2017; 12(9):e0185066. PMC: 5612686. DOI: 10.1371/journal.pone.0185066. View

5.
Bylund S, Kobyletzki L, Svalstedt M, Svensson A . Prevalence and Incidence of Atopic Dermatitis: A Systematic Review. Acta Derm Venereol. 2020; 100(12):adv00160. PMC: 9189744. DOI: 10.2340/00015555-3510. View